The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function
Abstract
Lymphocyte-specific interferon regulatory factor (LSIRF) (now called IRF4) is a transcription factor expressed only in lymphocytes. Mice deficient in IRF4 showed normal distribution of B and T lymphocyes at 4 to 5 weeks of age but developed progressive generalized lymphadenopathy. IRF4-deficient mice exhibited a profound reduction in serum immunoglobulin concentrations and did not mount detectable antibody responses. T lymphocyte function was also impaired in vivo; these mice could not generate cytotoxic or antitumor responses. Thus, IRF4 is essential for the function and homeostasis of both mature B and mature T lymphocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pip-deficient animals develop normal numbers of B cells (including λ-expressors) which cannot undergo activation”
From Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers (1999) · cites this paper as Mittrucker et al., 1997
In the citing paper
“whereas PIP function is necessary for maturation of B and T lymphocytes (34”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [34]
In the citing paper
“whereas PIP−/− animals exhibit a block in peripheral maturation of B cells and fail to produce antibodies in response to antigenic stimulation.”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [34]
In the citing paper
“Similarly, T cells of the mutant animals (PIP−/−) lack proliferative and cytotoxic responses (34”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [34]
In the citing paper
“IRF-4 2 / 2 mice develop progressive generalized lymphadenopathy and have severe defects in B and T lymphocyte function. (65)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [65]
In the citing paper
“IRF-4 2 / 2 mice develop progressive generalized lymphadenopathy and have severe defects in B and T lymphocyte function. (65)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [65]
Citations
Cites
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A. C., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,258
Self-citationInterleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment
Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A. I., & Alt, F. W. (1995) · Immunity · doi:10.1016/1074-7613(95)90180-9 · Cited by 1,079
Requirement for Transcription Factor IRF-1 in NO Synthase Induction in Macrophages
Kamijo, R., Harada, H., Matsuyama, T., Bosland, M. C., Gerecitano, J. F., Shapiro, D., Le, J., Koh, S. I., Kimura, T., Green, S. J., et al. (1994) · Science · doi:10.1126/science.7510419 · Cited by 843
Self-citationTanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., & Taniguchi, T. (1994) · Cell · doi:10.1016/0092-8674(94)90132-5 · Cited by 491
Self-citationPip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447
An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S., & Taniguchi, T. (1995) · Nature · doi:10.1038/376596a0 · Cited by 431
Self-citationBetz, A. G., Milstein, C., González‐Fernández, Á., Pannell, R., Larson, T., & Neuberger, M. S. (1994) · Cell · doi:10.1016/0092-8674(94)90316-6 · Cited by 379
An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
石原, 正. (1997) · Cited by 366
Transitional B cells are the target of negative selection in the B cell compartment.
Carsetti, R., Köhler, G., & Lamers, M. C. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.6.2129 · Cited by 358
Interferon-Induced Antiviral Actions and Their Regulation
Sen, G. C., & Ransohoff, R. M. (1993) · Advances in virus research · doi:10.1016/s0065-3527(08)60083-4 · Cited by 334
Flagged first, then by citations
Research works printed but not linked: 4
- Lamphier M., Taniguchi T., Immunologist 2, 167 (1994);
- Vaughan P. S., et al., ibid. 377, 362 (1995);
- Schmits R., et al., ibid., p. 1415.
- Healthy 5- to 7-week-old mice were used for all experiments. Mice were maintained according to the guidelines of the Canadian Council of Animal Care. H.-W.M. is a recipient of a grant from the Deutsche Forschungsgemeinschaft. The authors thank M. Bachmann G. Boehmelt G. Duncan D. Ferrick C. Furlonger D. Kägi F. Kiefer L. Marengere C. Paige J. Penninger M. Saunders R. Schmits D. Siderovski D. Speiser S. Yoshinaga and P. Waterhouse for providing reagents and for helpful comments.
Cited by
Sorted by citations
Items 501–583 of 583
Stochastic modeling of a gene regulatory network driving B cell development in germinal centers
Koshkin, A., Herbach, U., Martínez, M. R., Gandrillon, O., & Fabien Crauste, A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0301022 · Cited by 3
Sievert, E. P., Franke, M. C., Thomas, K., Yoon, Y., Shi, Y., & Sciammas, R. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115283 · Cited by 3
B-cell development and differentiation
Berek, C., Radbruch, A., & Schroeder, H. W. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04404-2.10008-9 · Cited by 3
Künzi, M. S., & Pitha, P. M. (2005) · Humana Press eBooks · doi:10.1385/1-59259-939-7:025 · Cited by 7
Pease, N. A., Fan, J., Keshari, S., Stratton, J., Gierlack, S., Sachan, A., Rarani, Z. H., Swaminathan, T., McGinnis, C. S., Zhang, W., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.23.649973 · Cited by 4
Zhou, L., Lin, P., Deng, G., Mo, L., Hong, C., Jiang, Z., Zhu, Y., Zhao, Y. D., Qi, Y., Hu, T., et al. (2024) · Parasites & Vectors · doi:10.1186/s13071-024-06543-8 · Cited by 2
IRF4 Mediates Immune Evasion to Facilitate EBV Transformation
Wang, L., Hensley, C. R., Rifat, J., Walker, A. D., Ning, K., Moorman, J. P., Yao, Z. Q., & Ning, S. (2025) · Viruses · doi:10.3390/v17070885 · Cited by 2
Miyaoka, M., Carreras, J., Kikuti, Y. Y., Ikoma, H., Nagase, S., Ito, A., Orita, M., Kawada, H., Sakai, R., Sato, Y., et al. (2026) · Histopathology · doi:10.1111/his.70117 · Cited by 2
Structural dynamics of the midnolin-proteasome during ubiquitin-independent substrate turnover
Zhu, C., Qin, L., Dai, Z., Zuo, P., Yang, A., Zhong, L., Lin, Z., & Liang, L. (2026) · Nature Communications · doi:10.1038/s41467-026-71002-0 · Cited by 2
Gene Expression during the Activation of Human B Cells
Zhang, Y. (2018) · InTech eBooks · doi:10.5772/intechopen.71863 · Cited by 2
Niri, T., Inoue, S.-I., Akazawa, S., Nishikido, S., Miwa, M., Kobayashi, M., Yui, K., Okita, M., Kawakami, A., & Abiru, N. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae093 · Cited by 2
Wedel, J., Kochupurakkal, N. M., Kong, S. W., Bose, S., Lee, J.-W., Maslyar, M., Alsairafi, B., MacLeod, K., Liu, K., Zhang, H., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci172218 · Cited by 2
Cottini, F., Anderson, K. C., & Tonon, G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-396967-5.00018-9 · Cited by 1
Immunoregulation of cytokines in infectious diseases (leprosy), future strategies.
Singh, R. P. (1998) · Japanese journal of leprosy · doi:10.5025/hansen.67.263 · Cited by 2
Immunodeficiencies Caused by B-Cell Defects
Bonilla, F. A., & Geha, R. S. (2004) · Elsevier eBooks · doi:10.1016/b978-012053641-2/50027-7 · Cited by 2
Identification and antiviral effect of Cherry Valley duck IRF4
Zhai, X., Hong, T., Zhang, T., Xing, B., Wang, J., Wang, X., Miao, R., Li, T., & Wei, L. (2021) · Poultry Science · doi:10.1016/j.psj.2021.101560 · Cited by 2
The Interferon Alpha Revival in CML
Talpaz, M., Mercer, J., & Hehlmann, R. (2016) · Hematologic malignancies · doi:10.1007/978-3-319-33198-0_14 · Cited by 2
Silverman, N. (2006) · Digital Commons - University of South Florida (University of South Florida) · Cited by 2
PROGNOSTIC MOLECULAR FACTORS AND ALGORITHMS IN DIFFUSE LARGE B-CELL LYMPHOMA
Nyman, H. (2010) · Työväentutkimus Vuosikirja · Cited by 2
Tian, L., Zhang, M., Guo, Y., Chang, S., Chen, Z. K., & Zhou, H. (2025) · Immunology · doi:10.1111/imm.70082 · Cited by 1
IRF4 (interferon regulatory factor 4)
Rasi, S., & Gaïdano, G. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/44637 · Cited by 1
Quand les cellules cancéreuses sont accros à un gène normal
Lamy, L. (2009) · médecine/sciences · doi:10.1051/medsci/20092519 · Cited by 1
Regulatory Roles of B Cells in Allergy and Inflammation
Takatsu, K., Ikutani, M., & Nagai, Y. (2011) · doi:10.1002/9781444346688.ch6 · Cited by 1
Early divergent B cell differentiation during antibody responses
Marshall, J. L. (2009) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 1
Mechanisms of Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2000) · Cited by 2
Erratum: How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis
Glynne, R. J., Akkaraju, S., Healy, J. I., Rayner, J., Goodnow, C. C., & Mack, D. H. (2000) · Nature · doi:10.1038/35030187 · Cited by 1
Osteolyse beim Multiplen Myelom : Untersuchungen am Zellmodell
Bergmann, M., & Lorenzen, J. (2005) · RWTH Publications (RWTH Aachen)
Cawkwell, L. B. (2013) · University of Birmingham Institutional Research Archive (University of Birmingham)
Regulation of positive regulatory domain I-binding factor 1 and its role in mantle cell lymphoma
Desai, S. (2010) · Digital Commons - University of South Florida (University of South Florida)
Rueda, A. F. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Moll, T. (2004) · Archive ouverte UNIGE (University of Geneva) · doi:10.13097/archive-ouverte/unige:306
IRF- 1 and IRF-4 Regulate Target Gene Expression via Interaction with DMP 1
Yamamoto, Y., Yamamoto, K., Yoshida, K., Kohno, T., Nogi, Y., & Matsuyama, T. (2003) · Nagasaki University's Academic Output SITE (Nagasaki University)
Self-citationPitha, P. M., & Alce, T. M. (2002) · Wiley Encyclopedia of Molecular Medicine · doi:10.1002/0471203076.emm0446
B Cell Growth, Differentiation and Malignancies
Tao, J., & Hu, C. A. (2012) · Springer eBooks · doi:10.1007/978-94-007-5028-9_1
Transcription Factors: Deciphering the Transcription Factor Network of Dendritic Cell Development
Hieronymus, T., & Zenke, M. (2006) · Wiley eBooks · doi:10.1002/9783527619696.ch4
Probing lymphocyte responses to modulation of the F0F1-ATPase by BZ-423
Wang, L. (2009) · Deep Blue (University of Michigan)
Regulation of transcription and analysis of drug targets in lymphoma and myeloma cells
Bolick, S. C. E. (2006) · Digital Commons - University of South Florida (University of South Florida)
Implication de la famille des facteurs de transcription IRF dans l’auto-immunité
Richez, C., Barnetche, T., Miceli‐Richard, C., Blanco, P., Moreau, J., Rifkin, I. R., & Schaeverbeke, T. (2010) · Revue du Rhumatisme · doi:10.1016/j.rhum.2010.04.031
IRF4 (interferon regulatory factor 4)
Shukla, V., & Lu, R. (2014) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/54034
Regulation of Humoral Immunity by Pim Kinases: A Dissertation
Willems, K. N. (2011) · eScholarship@UMassChan · doi:10.13028/w3jr-1r38
Expression and activation of STAT and IRF family transcription factors in mononuclear leukocytes
Lehtonen, A. (2005) · Työväentutkimus Vuosikirja
Prognostic Significance of Biomarkers of Diffuse Large B-cell Lymphomas
Park, S.-E., Park, S.-J., Park, N.-S., Chun, J.-M., Park, N.-H., Yang, Y.-J., Yun, K.-W., Yun, H., Kim, J., Jo, D., et al. (2005) · The Korean Journal of Hematology · doi:10.5045/kjh.2005.40.1.15
STUDIES ON THE EFFECTS OF ANTIGEN TYPE, APOPTOSIS AND AGE
Lindroth, K. (2004)
Ma, S., Shukla, V., Fang, L., Gould, K. A., Joshi, S. K., & Lu, R. (2013)
Pharmacogenomic modeling of bortezomib resistance in B cell malignancies
Stessman, H. A. F. (2013) · University of Minnesota Digital Conservancy (University of Minnesota)
Niedrigmaligne B-Zell-Lymphome
Mullerhermelink, H., & Ott, G. (2003) · Springer eBooks · doi:10.1007/978-3-642-59343-7_14
Regulation of B Cell Gene Expression and Function by Ikaros, Helios and Bcl6
Alinikula, J. (2010) · UTUPub (University of Turku)
Defining the role of Interferon Regulatory Factor 4 in Chronic Lymphocytic Leukemia.
Shukla, V. (2016) · DigitalCommons@UNMC
The roles of interferon regulatory factors in the murine models of colitis and sepsis
Yu, J. (2010) · Gutenberg Open Science · doi:10.25358/openscience-2232
Goldschmidt, H., Schneider, S., Strand, S., Ferreira, E. A., Moos, M., Lotz, M. C., Mutallib, S. A., & Oehlrich, N. (2013)
de Oliveira, M. L. G. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2017.tde-05012017-120156
Wilson, W. H. (2006) · Elsevier eBooks · doi:10.1016/b978-0-7216-0081-9.50017-0
Sun, T. (2017) · TSpace (University of Toronto)
Transcriptional control of tissue-resident memory T cell generation
Cvetkovski, F. (2019) · doi:10.7916/d8-n16c-b343
Gupta, D. D., Paul, C., Bollig, N., Bieringer, M., Staudenraus, D., Raifer, H., Menke, L., Camara, B., Roth, E. A., Daum, P., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-271184/v1
Allegra, A., Sant’Antonio, E., Musolino, C., & Ettari, R. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210914120228
Large B-cell lymphoma with IRF4 rearrangement
Васильевна, П. Л., Моисеева, Т. Н., Al-Radi, L. S., Kovrigina, A. M., Обухова, Т. Н., Goryacheva, S. R., Shupletsova, I. A., Магомедова, А. У., & Kravchenko, S. K. (2021) · Гематология и трансфузиология · doi:10.35754/0234-5730-2021-66-3-445-457
The Interferon-Alpha Revival in CML
Talpaz, M., Mercer, J., & Hehlmann, R. (2021) · Hematologic malignancies · doi:10.1007/978-3-030-71913-5_13
Gupta, D. D., Paul, C., Samel, N., Bieringer, M., Staudenraus, D., Marini, F., Raifer, H., Menke, L., Hansal, L., Camara, B., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.16.480573
Keegan, A. D. (2009) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1156915.616973
Mak, T. W., Penninger, J. M., Roder, J., Rossant, J., & Saunders, M. E. (1998) · Elsevier eBooks · doi:10.1016/b978-012466044-1/50357-4
Self-citationFaculty Opinions recommendation of IRF4 haploinsufficiency in a family with Whipple's disease.
Lionakis, M. S. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732842685.793572025
Faculty Opinions recommendation of CCL17 blockade as a therapy for osteoarthritis pain and disease.
Krawetz, R. J. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732995466.793552567
Boldison, J., Hopkinson, J. R., Davies, J. E., Pearson, J. A., Leete, P., Richardson, S. J., Morgan, N. G., & Wong, F. S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.19.492647
Editorial: Mechanisms of dysregulated antibody responses in inborn errors of immunity
Min, Q., Walter, J. E., Schroeder, H. W., Burrows, P. D., & Wang, J. O. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1335217
Bidwell, J. P., Robling, A. G., & Wek, R. C. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110562
Brugia malayi miRNAs and potential targets within the feline host (Felis catus)
Burkman, E. J., Tritten, L., Evans, C. C., Verocai, G. G., Sobotyk, C., Geary, T. G., & Moorhead, A. R. (2025) · Current Research in Parasitology and Vector-Borne Diseases · doi:10.1016/j.crpvbd.2025.100329
Wang, H., Chen, S., Tang, D., Chen, M., Peng, H., Zhang, G., & Wang, Y. (2025) · Pathology · doi:10.1016/j.pathol.2025.10.002 · Cited by 1
Sanz, A. M. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Sokolov, I. M., & Carlton, C. E. (2010) · INFM-OAR (INFN Catania) · doi:10.5281/zenodo.195866
Zhang, L., Tie, X., Che, F., Wang, G., Ge, Y., Li, B., & Yang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26596382
Caractérisation et modélisation des pathologies lymphoïdes présentant des gains du chromosome 21
Laurent, A. P. (2019) · theses.fr (ABES) · doi:10.70675/ed87382fza9bcz45fdz8589zd8c7fb99d3a9
A novel small-molecule inhibitor of IRF4 selectively suppresses multiple myeloma
Zhang, L., Ding, X., Wu, M., Zhang, J.-Z., Chen, H., Liu, M., Qiu, W.-W., & Yi, Z. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102176
Won, J., Kim, J., Singh, A. K., & Singh, I. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1797609
Malhotra, N. (2012) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/p4kw-qf21
Identification and analysis of omentum derived suppressor cells in regards to Th17 inhibition
Huang, N. (2014) · Loyola eCommons (Loyola University of Chicago)
IRF4 Does the Balancing Act: A Dissertation
Nayar, R. (2015) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2302t
Metadata
- Authors
- Mittrücker, H.-W., Matsuyama, T., Grossman, A., Kündig, T. M., Potter, J., Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P. S., & Mak, T. W.
- Affiliations
- University of Toronto (CA)
- Nagasaki University (JP)
- B. Patterson, Department of Oncologic Pathology, Ontario Cancer Institute, 610 University Avenue, Toronto, Ontario, M5G 2C1, Canada.
- Venue
- Science
- Published
- 1997-01-24
- Volume
- 275
- Issue
- 5299
- Pages
- 540-543
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2022687427
- Cited by
- 583
- References
- 21
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 12 · 2023: 20 · 2022: 23 · 2021: 23 · 2020: 17 · 2019: 15 · 2018: 16 · 2017: 20 · 2016: 15 · 2015: 18 · 2014: 25 · 2013: 32 · 2012: 20
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- IRF4, transcription factors, B cells, T cells, lymphocyte homeostasis, lymphadenopathy, antibody deficiency, antibody response, cytotoxic T lymphocytes, antitumor immunity
- MeSH terms
- Lymphadenopathy, Interferon Regulatory Factor-4, Animals, Antibody Formation, B-Lymphocytes, Cell Differentiation, Cells, Cultured, Homeostasis, Mice, Inbred BALB C, T-Lymphocytes, Cytotoxic, Transcription, Genetic, Mice, SCID, Mice, Knockout, Cell Proliferation, Interferon Regulatory Factors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review